<DOC>
	<DOC>NCT02912533</DOC>
	<brief_summary>The purpose of this study is to investigate the safety and efficacy for 52-week dosing of JR-131 in renal anemia patients with chronic kidney disease (CKD).</brief_summary>
	<brief_title>A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<criteria>Patients being treated with erythropoiesis stimulating agent. Patients having complication or history of a cardiovascular / lung / brain infarction. Patients having a pronounced hemorrhagic lesion.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>